Schahram Akbarian, MD, PhD
img_Schahram Akbarian
PROFESSOR | Genetics and Genomic Sciences
PROFESSOR | Psychiatry
PROFESSOR | Neuroscience
Research Topics
Depression, Schizophrenia
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Dr. Akbarian’s research interests include epigenetic determinants of normal and diseased human brain development, with implications for the neurobiology of major psychiatric disorders such as schizophrenia, autism and depression. This work is largely focused on charting DNA and histone modification landscapes, and more generally, genome organization, in specific cell types from brain. These clinical studies are complemented by preclinical research, exploring novel avenues for treatment of psychiatric disease in cell cultures and animal models with specific mutations in proteins regulating chromatin and chromosomal architectures.

Key words: nucleosome, epigenome, histone methylation, neuronal nucleus, prefrontal cortex, mood disorder, schizophrenia, autism spectrum disorder
Publications

Selected Publications

Single chromatin fiber profiling and nucleosome position mapping in the human brain. Cyril J. Peter, Aman Agarwal, Risa Watanabe, Bibi S. Kassim, Xuedi Wang, Tova Y. Lambert, Behnam Javidfar, Viviana Evans, Travis Dawson, Maya Fridrikh, Kiran Girdhar, Panos Roussos, Sathiji K. Nageshwaran, Nadejda M. Tsankova, Robert P. Sebra, Mitchell R. Vollger, Andrew B. Stergachis, Dan Hasson, Schahram Akbarian. Cell Reports Methods

Nucleus accumbens myocyte enhancer factor 2C mediates the maintenance of peripheral nerve injury–induced physiological and behavioral maladaptations. Randal A. Serafini, Zahra Farzinpour, Vishwendra Patel, Abigail M. Kelley, Molly Estill, Kerri D. Pryce, Farhana Sakloth, Collin D. Teague, Angelica Torres-Berrio, Eric J. Nestler, Li Shen, Schahram Akbarian, Anushree N. Karkhanis, Robert D. Blitzer, Venetia Zachariou. Pain

Mapping recurrent mosaic copy number variation in human neurons. Chen Sun, Kunal Kathuria, Sarah B. Emery, Byung Jun Kim, Ian E. Burbulis, Joo Heon Shin, Joseph G. Gleeson, Martin W. Breuss, Xiaoxu Yang, Danny Antaki, Changuk Chung, Dan Averbuj, Laurel L. Ball, Subhojit Roy, Daniel Weinberger, Andrew Jaffe, Apua Paquola, Jennifer Erwin, Richard Straub, Rujuta Narurkar, Gary Mathern, Christopher A. Walsh, Alice Lee, August Yue Huang, Alissa D’Gama, Caroline Dias, Eduardo Maury, Javier Ganz, Michael Lodato, Michael Miller, Pengpeng Li, Rachel Rodin, Rebeca Borges-Monroy, Robert Hill, Sara Bizzotto, Sattar Khoshkhoo, Sonia Kim, Zinan Zhou, Peter J. Park, Alison Barton, Alon Galor, Chong Chu, Craig Bohrson, Doga Gulhan, Elaine Lim, Euncheon Lim, Giorgio Melloni, Andrew J. Chess, Chaggai Rosenbluh, Schahram Akbarian. Nature Communications

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Akbarian has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.